FDA approves brincidofovir (Tembexa) tablets and oral suspension for treatment of Smallpox

Approval for this nucleotide analog lipid-conjugate designed to mimic natural monoacyl phospholipid to achieve effective intracellular concentrations of active antiviral metabolite, cidofovir diphosphate is based on efficacy data from 2 lethal orthopoxvirus animal studies.

Source:

Biospace Inc.